Uterus Transplantation As Infertility Treatment in Gynecological Cancer Survivors: A Systematic Review

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 Jun 19

PMID 38892883

Authors

Ermioni Tsarna

Anna Eleftheriades

Alkis Matsas

Olga Triantafyllidou

Panagiotis Christopoulos

Affiliations

Soon will be listed here.

Abstract

: The aim of this systematic review is to summarize the evidence regarding the acceptance of uterine transplantation as infertility treatment among gynecological cancer survivors, surgical and pregnancy outcomes post-transplantation for gynecological cancer survivors, as well as relevant adverse events. : PubMed and Embase were searched for records published since 2000, and extensive reference screening was performed. : Out of 1901 unique records identified, 7 are included in this review; 4 examined the proportion of gynecological cancer survivors among applicants for uterine transplantation, 2 examined rejection rates, pregnancy rates, and outcomes after uterine transplantation among gynecological cancer survivors, and 2 reported the frequency of relevant adverse events. Among the applicants, 60/701 (8.6%) were gynecological cancer survivors, only 1 transplanted patient was a cervical cancer survivor and achieved two live births after eight embryo transfers, and 2/27 (7.4%) of uterus transplantation recipients were diagnosed with CIN post-transplantation. : Uterus transplantation can be regarded as an infertility treatment for absolute uterine factor infertility (AUFI), although only one gynecological cancer survivor has received a uterus transplantation. The efficacy, safety, and ethical considerations for gynecological cancer survivors need to be addressed for uterine transplantation to become an infertility treatment option for AUFI among gynecological cancer survivors.

References

Brannstrom M, Dahm-Kahler P . Uterus transplantation and fertility preservation. Best Pract Res Clin Obstet Gynaecol. 2019; 55:109-116. DOI: 10.1016/j.bpobgyn.2018.12.006. View

Agraharkar M, Cinclair R, Kuo Y, Daller J, Shahinian V . Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kidney Int. 2004; 66(1):383-9. DOI: 10.1111/j.1523-1755.2004.00741.x. View

Arian S, Flyckt R, Farrell R, Falcone T, Tzakis A . Characterizing women with interest in uterine transplant clinical trials in the United States: who seeks information on this experimental treatment?. Am J Obstet Gynecol. 2016; 216(2):190-191. DOI: 10.1016/j.ajog.2016.11.1028. View

Testa G, Koon E, Johannesson L, McKenna G, Anthony T, Klintmalm G . Living Donor Uterus Transplantation: A Single Center's Observations and Lessons Learned From Early Setbacks to Technical Success. Am J Transplant. 2017; 17(11):2901-2910. DOI: 10.1111/ajt.14326. View

Brannstrom M . The Swedish uterus transplantation project: the story behind the Swedish uterus transplantation project. Acta Obstet Gynecol Scand. 2015; 94(7):675-679. DOI: 10.1111/aogs.12661. View

Hinten F, Meeuwis K, van Rossum M, de Hullu J . HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients. Crit Rev Oncol Hematol. 2012; 84(2):161-80. DOI: 10.1016/j.critrevonc.2012.02.008. View

Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J . ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol. 2015; 27(1):16-41. DOI: 10.1093/annonc/mdv484. View

. 22 Annual State of the Art Winter Symposium. Am J Transplant. 2022; 22 Suppl 1:11-102. DOI: 10.1111/ajt.16915. View

Stubblefield M . Radiation fibrosis syndrome: neuromuscular and musculoskeletal complications in cancer survivors. PM R. 2011; 3(11):1041-54. DOI: 10.1016/j.pmrj.2011.08.535. View

10.

Acuna S, Huang J, Daly C, Shah P, Kim S, Baxter N . Outcomes of Solid Organ Transplant Recipients With Preexisting Malignancies in Remission: A Systematic Review and Meta-Analysis. Transplantation. 2016; 101(3):471-481. DOI: 10.1097/TP.0000000000001192. View

11.

Sallee C, Margueritte F, Marquet P, Piver P, Aubard Y, Lavoue V . Uterine Factor Infertility, a Systematic Review. J Clin Med. 2022; 11(16). PMC: 9410422. DOI: 10.3390/jcm11164907. View

12.

Hammond-Browning N . UK criteria for uterus transplantation: a review. BJOG. 2019; 126(11):1320-1326. DOI: 10.1111/1471-0528.15844. View

13.

Huet S, Tardieu A, Filloux M, Essig M, Pichon N, Therme J . Uterus transplantation in France: for which patients?. Eur J Obstet Gynecol Reprod Biol. 2016; 205:7-10. DOI: 10.1016/j.ejogrb.2016.08.027. View

14.

Rob L, Skapa P, Robova H . Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol. 2010; 12(2):192-200. DOI: 10.1016/S1470-2045(10)70084-X. View

15.

Johannesson L, Kvarnstrom N, Molne J, Dahm-Kahler P, Enskog A, Diaz-Garcia C . Uterus transplantation trial: 1-year outcome. Fertil Steril. 2014; 103(1):199-204. DOI: 10.1016/j.fertnstert.2014.09.024. View

16.

Michael Clark J, Sanders S, Carter M, Honeyman D, Cleo G, Auld Y . Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial. J Med Libr Assoc. 2020; 108(2):195-207. PMC: 7069833. DOI: 10.5195/jmla.2020.834. View

17.

Strome M, Stein J, Esclamado R, Hicks D, Lorenz R, Braun W . Laryngeal transplantation and 40-month follow-up. N Engl J Med. 2001; 344(22):1676-9. DOI: 10.1056/NEJM200105313442204. View

18.

Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-263. DOI: 10.3322/caac.21834. View

19.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

20.

Arora K, Blake V . Uterus transplantation: ethical and regulatory challenges. J Med Ethics. 2013; 40(6):396-400. DOI: 10.1136/medethics-2013-101400. View